Insiders · NAVB

NAVB insider transactions

Navidea Biopharmaceuticals Inc. (NAVB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NAVB

• 911d
  Scott John K Jr. disposed of 2,270 units of Series G Redeemable Preferred Stock, closing all direct ownership in the company (SEC Form 4)

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 926d
  Moss Dana J was granted 616,667 shares, increasing direct ownership by 247% to 866,667 units (SEC Form 4)

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 926d
  Stefanelli Jill was granted 691,667 shares, increasing direct ownership by 277% to 941,667 units (SEC Form 4)

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1023d
  SEC Form 3 filed by new insider Dais Craig

  3 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1052d
  SEC Form 4 filed by Moss Dana J

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1052d
  SEC Form 3 filed by new insider Moss Dana J

  3 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1069d
  SEC Form 4 filed by Scott John K Jr.

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1084d
  SEC Form 4 filed by Scott John K Jr.

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1087d
  SEC Form 4 filed by Stefanelli Jill

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1090d
  SEC Form 3 filed by new insider Stefanelli Jill

  3 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1281d
  SEC Form 4: Witter Malcolm G was granted 1,250 shares, increasing direct ownership by 0.76% to 165,138 units (Amendment)

  4/A - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1281d
  SEC Form 4: Witter Malcolm G was granted 1,250 shares, increasing direct ownership by 0.77% to 163,888 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1281d
  SEC Form 4: Wilson Joshua M. was granted 30,000 shares

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1281d
  SEC Form 4: Scott John K Jr. was granted 1,250 shares, increasing direct ownership by 0.02% to 8,109,645 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1281d
  SEC Form 4: Cappello Alexander L was granted 1,250 shares, increasing direct ownership by 2% to 67,727 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1281d
  SEC Form 4: Bhalla Amit was granted 1,250 shares, increasing direct ownership by 2% to 71,818 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1310d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 163,888 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1310d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares, increasing direct ownership by 0.03% to 8,108,395 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1310d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 4% to 66,477 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1310d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 4% to 70,568 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1317d
  SEC Form 3 filed by new insider Wilson Joshua M.

  3 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1338d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 161,388 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1338d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 4% to 63,977 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1338d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares, increasing direct ownership by 0.03% to 8,105,895 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1338d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 4% to 68,068 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1359d
  SEC Form 4: Rosol Michael Stanley was granted 41,150 shares, increasing direct ownership by 282% to 55,725 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1371d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 158,888 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1371d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares, increasing direct ownership by 0.03% to 8,103,395 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1371d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 4% to 61,477 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1371d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 4% to 65,568 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1402d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 156,388 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1402d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares, increasing direct ownership by 0.03% to 8,100,895 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1402d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 4% to 58,977 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1402d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 4% to 63,068 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1429d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 153,888 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1429d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares, increasing direct ownership by 0.03% to 8,098,395 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1429d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 5% to 56,477 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1429d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 4% to 60,568 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1463d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 151,388 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1463d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares, increasing direct ownership by 0.03% to 8,095,895 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1463d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 5% to 53,977 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1463d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 4% to 58,068 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1492d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 148,888 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1492d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares and bought 3,260 units of Series G Redeemable Preferred Stock, decreasing direct ownership by 100% to 3,260 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1492d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 5% to 51,477 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1492d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 5% to 55,568 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1525d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 146,388 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1525d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 5% to 48,977 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1525d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares, increasing direct ownership by 0.03% to 8,090,895 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1525d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 5% to 53,068 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1548d
  SEC Form 4 filed by Rosol Michael Stanley (Amendment)

  4/A - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1555d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 143,888 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1555d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares, increasing direct ownership by 0.03% to 8,088,395 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1555d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 6% to 46,477 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1555d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 5% to 50,568 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1583d
  SEC Form 4: Witter Malcolm G was granted 2,500 shares, increasing direct ownership by 2% to 141,388 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1583d
  SEC Form 4: Scott John K Jr. was granted 2,500 shares, increasing direct ownership by 0.03% to 8,085,895 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1583d
  SEC Form 4: Cappello Alexander L was granted 2,500 shares, increasing direct ownership by 6% to 43,977 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1583d
  SEC Form 4: Bhalla Amit was granted 2,500 shares, increasing direct ownership by 5% to 48,068 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)
• 1597d
  SEC Form 4: Rosol Michael Stanley was granted 7,728 shares, increasing direct ownership by 113% to 14,575 units

  4 - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) (Issuer)